vesnarinone has been researched along with Adenocarcinoma, Basal Cell in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " We have studied the anti-cancer effect of vesnarinone in combination with cisplatin, VP-16 (etoposide) and gemcitabine, against human lung cancer cell lines (PC-9 and Lu 134A) using the MTT assay and isobologram analysis." | 1.30 | Effect of vesnarinone in combination with anti-cancer drugs on lung cancer cell lines. ( Fujita, M; Higashino, K; Tsuchida, T, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nio, Y | 1 |
| Ohmori, H | 1 |
| Minari, Y | 1 |
| Hirahara, N | 1 |
| Sasaki, S | 1 |
| Takamura, M | 1 |
| Tamura, K | 1 |
| Fujita, M | 1 |
| Tsuchida, T | 1 |
| Higashino, K | 1 |
2 other studies available for vesnarinone and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
A quinolinone derivative, vesnarinone (OPC-8212), significantly inhibits the in vitro and in vivo growth of human pancreatic cancer cell lines.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Division; Cell Survival; Collagen; Drug Combina | 1997 |
Effect of vesnarinone in combination with anti-cancer drugs on lung cancer cell lines.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cell Division | 1999 |